CRANBROOK SURGERY — All Prescriptions & Medications — Page 2
Practice Code: F86698 | ILFORD, IG2 6RJ
Showing results 51-100 of 398
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Other emollient preparations | 324 | 174.2K | £2.2K | -46.1% ▼ |
| Pregabalin | 314 | 16.1K | £687 | -75.0% ▼ |
| Budesonide | 312 | 404 | £8.1K | -42.4% ▼ |
| Prednisolone | 292 | 11.6K | £694 | -63.5% ▼ |
| Risperidone | 291 | 5,465 | £419 | +15.0% ▲ |
| Perindopril erbumine | 272 | 9,637 | £895 | -48.8% ▼ |
| Latanoprost | 270 | 7,693 | £2.4K | -44.4% ▼ |
| 268 | 269 | £1.5K | +13.5% ▲ | |
| Betamethasone valerate | 262 | 16.8K | £1.2K | -31.9% ▼ |
| Propranolol hydrochloride | 259 | 15.5K | £1.1K | -75.7% ▼ |
| 255 | 102.1K | £1.8K | -3.3% ▼ | |
| Flucloxacillin sodium | 244 | 9,568 | £485 | -45.7% ▼ |
| 240 | 27.3K | £874 | -49.4% ▼ | |
| Apixaban | 235 | 12.0K | £1.6K | -82.3% ▼ |
| Cetirizine hydrochloride | 232 | 19.1K | £1.1K | -53.6% ▼ |
| Bendroflumethiazide | 223 | 9,086 | £149 | -71.2% ▼ |
| Rosuvastatin calcium | 218 | 7,784 | £421 | -75.7% ▼ |
| 218 | 29.0K | £860 | -21.2% ▼ | |
| Ezetimibe | 216 | 8,848 | £1.5K | -69.6% ▼ |
| Sildenafil (Erectile Dysfunction) | 215 | 2,124 | £297 | -57.3% ▼ |
| Spironolactone | 214 | 5,194 | £464 | -60.3% ▼ |
| Pravastatin sodium | 214 | 8,757 | £391 | -34.1% ▼ |
| Lactulose | 213 | 120.5K | £1.1K | -35.3% ▼ |
| Aripiprazole | 209 | 5,919 | £2.0K | -17.9% ▼ |
| Alendronic acid | 200 | 1,292 | £292 | -73.3% ▼ |
| Hydrocortisone | 200 | 5,880 | £1.8K | -55.4% ▼ |
| Promethazine hydrochloride | 198 | 9,147 | £739 | -44.6% ▼ |
| 196 | 26.5K | £1.2K | +49.6% ▲ | |
| Hydroxychloroquine sulfate | 194 | 7,816 | £567 | +0.2% vs avg |
| Sodium valproate | 190 | 31.0K | £2.0K | -40.3% ▼ |
| Atenolol | 189 | 9,156 | £197 | -68.7% ▼ |
| Zopiclone | 187 | 4,360 | £386 | -66.2% ▼ |
| Levetiracetam | 184 | 13.6K | £2.5K | -59.8% ▼ |
| Clobetasone butyrate | 183 | 8,205 | £1.1K | -10.3% ▼ |
| Alginic acid compound preparations | 182 | 93.6K | £1.3K | -68.9% ▼ |
| Insulin aspart | 173 | 1,401 | £8.7K | -54.6% ▼ |
| Memantine hydrochloride | 170 | 2,761 | £558 | -48.5% ▼ |
| Carbocisteine | 169 | 14.4K | £816 | -68.3% ▼ |
| Biphasic insulin aspart | 169 | 1,398 | £8.3K | +66.4% ▲ |
| Mirabegron | 165 | 3,698 | £3.4K | -58.9% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 164 | 4,227 | £212 | -27.4% ▼ |
| Edoxaban | 161 | 4,928 | £8.2K | -77.0% ▼ |
| Fluticasone furoate | 160 | 174 | £1.2K | -17.4% ▼ |
| Prochlorperazine maleate | 159 | 6,321 | £312 | -21.3% ▼ |
| Insulin glargine | 152 | 952 | £6.8K | -46.5% ▼ |
| Isosorbide mononitrate | 151 | 4,032 | £579 | -77.2% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 149 | 15.4K | £565 | -51.4% ▼ |
| Fluticasone propionate (Nasal) | 149 | 565 | £2.0K | +2.3% ▲ |
| Betahistine hydrochloride | 147 | 9,870 | £395 | -38.4% ▼ |
| Glimepiride | 141 | 3,756 | £120 | +52.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.